|
Volumn 21, Issue 11, 2002, Pages 1349-1360
|
Cardiac disease outcomes in clinical trials;Marcadores de doença cardíaca em ensaios clínicos
|
Author keywords
Disease markers; Endpoints; Evidence based cardiology; Randomized controlled trials; Surrogate endpoints
|
Indexed keywords
ANGINA PECTORIS;
ARTERY DISEASE;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMPLICATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CORONARY ARTERY OBSTRUCTION;
DISEASE MARKER;
EVIDENCE BASED MEDICINE;
HEALTH CARE COST;
HEART ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HEART DISEASE;
HEART FAILURE;
HEART INFARCTION PREVENTION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HOSPITAL ADMISSION;
HUMAN;
HYPERTENSION;
LABORATORY TEST;
MEDLINE;
MORTALITY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
STABLE ANGINA PECTORIS;
STROKE;
TRANSIENT ISCHEMIC ATTACK;
UNSTABLE ANGINA PECTORIS;
DATABASES, FACTUAL;
HEART DISEASES;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0036868809
PISSN: 08702551
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (9)
|